Sort
51,570 grants matching “autoimmune disease”
Induced tolerogenic dendritic cell therapy of allergic diseases
$590,342Ulrich H Von Andrian · Massachusetts General Hospital · U19 · FY2015 · AI
Novel RORgamma antagonists for inflammation and autoimmune disease
$590,333F Javier Piedrafita · Torrey Pines Inst For Molecular Studies · R01 · FY2016 · AI
Identifying and preventing antigen specific T cells in diabetes
$590,331Brian T Fife · University Of Minnesota · R01 · FY2022 · AI
Identifying and preventing antigen specific T cells in diabetes
$590,331Brian T Fife · University Of Minnesota · R01 · FY2023 · AI
Identifying and preventing antigen specific T cells in diabetes
$590,331Brian T Fife · University Of Minnesota · R01 · FY2025 · AI
Identifying and preventing antigen specific T cells in diabetes
$590,331Brian T Fife · University Of Minnesota · R01 · FY2024 · AI
ASSEMBLY & EXPRESSION OF IG & TCR VARIABLE REGION GENES
$590,180Frederick W Alt · Immune Disease Institute, Inc. · R01 · FY2009 · AI
GENE REGULATORY EVENTS IN ESTABLISHING MATURE T CELL TOLERANCE
$590,169Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
ZBP1 activation
$590,017Andrew Atwell Oberst · University Of Washington · R01 · FY2024 · AI
Identifying and preventing antigen specific T cells in diabetes
$590,015Brian T Fife · University Of Minnesota · R01 · FY2021 · AI
Applying Bioinformatics to Research in Immune, Muscle, and Bone Diseases
$589,821Massimo Gadina · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIH · FY2012 · AR
IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis
$589,776Jessica A Hamerman · Benaroya Research Inst At Virginia Mason · R01 · FY2020 · AR
In Vivo Prevention of Murine GVHD
$589,718Bruce R. Blazar · University Of Minnesota · R37 · FY2024 · AI
In Vivo Prevention of Murine GVHD
$589,718Bruce R. Blazar · University Of Minnesota · R37 · FY2025 · AI
In Vivo Prevention of Murine GVHD
$589,718Bruce R. Blazar · University Of Minnesota · R37 · FY2023 · AI
Myeloid sphingolipid regulation of tissue resolution and regeneration responses
$589,706Timothy Tun Hla · Boston Children'S Hospital · R01 · FY2025 · AI
Myeloid sphingolipid regulation of tissue resolution and regeneration responses
$589,706Timothy Tun Hla · Boston Children'S Hospital · R01 · FY2024 · AI
Myeloid sphingolipid regulation of tissue resolution and regeneration responses
$589,706Timothy Tun Hla · Boston Children'S Hospital · R01 · FY2023 · AI
Islet encapsulation to elicit localized immunosuppression and immune modulation following transplantation
$589,588Hubert M Tse · University Of Kansas Medical Center · R01 · FY2023 · DK
Nutrition and Metabolic Status in Youth with Type 1 DM: SEARCH Ancillary Study
$589,513Elizabeth J Mayer-Davis · Univ Of North Carolina Chapel Hill · R01 · FY2011 · DK
Developing small molecule inhibitors of TLR8 for treatment of rheumatoid arthritis
$589,482Albert F Candia · Dynavax Technologies Corporation · R44 · FY2016 · AI
Development of Kv1.3 Monoclonal Antibodies Targeting TEM Cells for Treating Autoimmune Disorders
$589,456Joseph Benjamin Rucker · Integral Molecular · R44 · FY2022 · GM
Role of impaired cognitive states & risk factors in conversion to mixed dementias
$589,339Richard J Kryscio · University Of Kentucky · R01 · FY2022 · AG
Unraveling the tolerogenic potential of lymph node fibroblastic reticular networks in autoimmune diabetes
$589,331Remi J Creusot · Columbia University Health Sciences · R01 · FY2025 · DK
Vasculitis and Translational Medicine
$589,258Peter Grayson · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2018 · AR